Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
The gene, CCR4, was present in higher levels in patients with a good prognosis, even in those diagnosed with late stage colorectal cancer.
10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.
The agency said it is unaware of data establishing that Inova’s tests helps patients or clinicians make appropriate treatment decisions for the listed drugs.
The DNA test available to healthy individuals analyzes all 59 medically actionable genes identified by the American College of Medical Genetics and Genomics.
There is no doubt the age of wearable monitors is upon us. Sales of physical activity monitors have increased dramatically from 15 million in...
These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
Multidimensional, computationally rich approaches represent the next wave of innovation, taking personalized medicine to the next level, while demanding more of practitioners, who in...
A leader in cancer genomics research, new AACR president recaps her research over the past five years and looks ahead to what advances my lie ahead.
LabCorp’s Covance Drug Development business will be the first global contract research organization to offer services on Mission Bio’s Tapestri Platform for single-cell DNA genomics.